Having drawn immense investor demand during the bookbuilding phase, nutraceutical manufacturer Orzax successfully completed its initial public offering (IPO) and began trading on Borsa Istanbul's Stars Market under the ticker "ORZAX". The Bell Ceremony for the company, which secured bids from approximately 1 million investors to reach a TRY 3.6 billion volume, was celebrated on Tuesday, July 7.
Read More
